Skip to main content
Home
FULL MENU Close Menu
Home
Home

Timothy S. Rei

Article

Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies

Author:
Keith R. Campbell, PharmD, MBA, CDE
Michael E. Cobble, MD, FNLA
Timothy S. Rei
  • Read More

Article

Glucose-lowering effects of incretin-based therapies

Author:
Keith R. Campbell, PharmD, MBA, CDE
Michael E. Cobble, MD, FNLA
Timothy S. Rei
  • Read More

Article

Safety, tolerability, and nonglycemic effects of incretin-based therapies

Author:
Keith R. Campbell, PharmD, MBA, CDE
Michael E. Cobble, MD, FNLA
Timothy S. Rei
  • Read More

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close